Clinical and angiographic outcomes of patients treated with everolimus-eluting stents or first-generation paclitaxel-eluting stents for unprotected left main disease

Journal of the American College of Cardiology

Volumn 60, Issue 14, 2012, Pages 1217-1222

  Valenti, Renato ^a   Migliorini, Angela ^a   Parodi, Guido ^a   Carrabba, Nazario ^a   Vergara, Ruben ^a   Dovellini, Emilio V ^a   Antoniucci, David ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

drug eluting stent(s); everolimus eluting stent(s); paclitaxel eluting stent(s)

Indexed keywords

EVEROLIMUS; PACLITAXEL;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEOINTIMA; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; UNPROTECTED LEFT MAIN DISEASE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DEATH; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; REGISTRIES; SIROLIMUS; TREATMENT OUTCOME;

EID: 84866652789     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.05.038     Document Type: Article

References (15)

1. P.W. Serruys, P.N. Ruygrok, J. Neuzner A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial EuroIntervention 2 2006 286 294
2. G.W. Stone, M. Midei, W. Newman SPIRIT III Investigators Randomized comparison of everolimus-eluting and paclitaxel-eluting stents Two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial Circulation 119 2009 680 686
3. G.W. Stone, A. Rizvi, W. Newman Spirit IV Investigators Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
4. E. Kedhi, K.S. Joesoef, E. McFadden Second generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209
5. P.W. Serruys, M.C. Morice, A.P. Kappetein Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
6. M.C. Morice, P.W. Serruys, A.P. Kappetein Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial Circulation 121 2010 2645 2653
7. B.E. Claessen, G.W. Stone, P.C. Smits Would SYNTAX have been a positive trial if XIENCE V had been used instead of TAXUS? A meta-analysis of a first-generation vs. a second-generation drug-eluting stent system Neth Heart J 18 2010 451 453
8. A. Migliorini, R. Valenti, R. Marcucci High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease Circulation 120 2009 2214 2221
9. A. Migliorini, R. Valenti, G. Parodi The impact of right coronary artery chronic total occlusion on clinical outcome of patients undergoing percutaneous coronary intervention for unprotected left main disease J Am Coll Cardiol 58 2011 125 130 5
10. P. Michel, F. Roques, S.A. Nashef EuroSCORE Project Group Logistic or additive EuroSCORE for high-risk patients? Eur J Cardiothorac Surg 23 2003 684 687 discussion 687 (Pubitemid 36566559)
11. D.E. Cutlip, S. Windecker, R. Mehran Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
12. C. Godino, G. Parodi, S. Furuichi Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry) EuroIntervention 5 2010 906 916
13. R. Valenti, R. Vergara, A. Migliorini Comparison of everolimus-eluting stent with paclitaxel-eluting stent in long chronic total occlusions Am J Cardiol 107 2011 1768 1771
14. J. Mehilli, A. Kastrati, R.A. Byrne Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease J Am Coll Cardiol 5 2009 1760 1768
15. M.C. Morice, T.E. Feldman, M.J. Mack et al. Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS) EuroIntervention 7 2011 670 679